Quantcast

Latest Venous ulcer Stories

2009-12-22 08:17:00

RICHMOND, Virginia and ROSH HA'AYIN, Israel, December 22 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $2.5 million. The round was led by Eli Gilboa, CPA, of Gilboa & Licht, who serves as the company's active chairman at a company valuation of US$18.5 million. To date, the company has raised a total US$10 million. Proceeds will be...

2009-12-16 11:10:00

SAN DIEGO, Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) The study titled, "A history of foot ulcer increases mortality among persons with...

2009-12-14 08:15:00

SAN DIEGO, Dec. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced a presentation titled, "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," at the Tenth Annual Wound Healing: Science and Industry Conference held December 10-13, 2009 in St. Thomas, U.S. Virgin Islands. The conference is attended by top industry leaders and renowned researchers in the field of advanced wound healing. Dr. Barbara K. Sosnowski, Cardium's Vice...

2009-12-03 09:50:00

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that its wholly-owned subsidiary, Tissue Repair Company, submitted a 510(k) premarket notification filing with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its Excellagen(TM) product candidate based on positive data from the Company's recently completed Phase 2b Matrix clinical study. Today's submission with the FDA covers ExcellagenXL(TM) and ExcellagenFX(TM),...

2009-11-19 06:30:00

ST. PETERSBURG, Fla., Nov. 19 /PRNewswire-FirstCall/ -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN), supports the American Medical Association's creation of the new Category (1) Current Procedural Terminology (CPT) Code 29581, "Application of multi-layer venous wound compression system, below knee." The new code goes into effect on January 1, 2010. "Venous leg ulcers afflict approximately one percent of...

2009-11-03 07:45:00

FORT WORTH, Texas, Nov. 3 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM), announced today that a clinical study, "Activated Collagen Accelerates Wound Repair and Modulates Cytokine Production in Whole Blood and PBMC Cultures" was presented at the Tri-Society Annual Conference 2009 of the Society for Leukocyte Biology, International Cytokine Society, & International Society for Interferon and Cytokine Research, Cellular...

2009-11-02 09:30:00

SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate. ExcellagenXL is an advanced wound care management medical device, which is a customized collagen-based topical gel designed for use by physicians in patients with topical wounds, which include diabetic ulcers as well as...

2009-10-23 12:17:00

ADDISON, Texas, Oct. 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas. Highlights of the clinical experience presented by Dr. Bohn's poster presentations include: A stagnated traumatic wound that was...

2009-10-22 13:21:00

LONDON, October 22 /PRNewswire/ -- Systagenix Wound Management, has unveiled SILVERCEL* Non-Adherent dressing a powerful new antimicrobial silver dressing with a unique non -adherent layer that controls infection and minimises trauma with each dressing change. SILVERCEL* Non- Adherent dressing can be easily removed in one piece without adhering to the wound bed. Suitable for infected, chronic and acute wounds, SILVERCEL* Non -Adherent dressing has been uniquely designed to leave...

2009-10-22 07:30:00

ADDISON, Texas, Oct. 22 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that a poster highlighting the benefits of using Altrazeal(TM) in the home care market segment will be among the Altrazeal(TM) posters being presented at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" in San Antonio, Texas from October 22-25. The poster, presented by Bobbie Spitz, R.N., M.S.N., CWS, from Aurora Home Health visiting nurse association of...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'